Blueprint Medicines exotic insider transaction detected

BPMC Stock  USD 91.78  4.70  4.87%   
About 63% of Blueprint Medicines' investor base is looking to short. The analysis of the overall investor sentiment regarding Blueprint Medicines Corp suggests that many traders are alarmed. The current market sentiment, together with Blueprint Medicines' historical and current headlines, can help investors time the market. In addition, many technical investors use Blueprint Medicines Corp stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Blueprint Medicines Corp executive. Unconventional Insider trading

Read at macroaxis.com
Blueprint insider trading alert for general transaction of common stock by Third Rock Ventures Ii Lp, the corporate stakeholder, on 10th of July 2023. This event was filed by Blueprint Medicines Corp with SEC on 2017-02-09. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Blueprint Medicines' cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Blueprint Medicines' relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Blueprint Medicines Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Blueprint Medicines can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Blueprint Medicines Fundamental Analysis

We analyze Blueprint Medicines' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Blueprint Medicines using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Blueprint Medicines based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Earnings Per Share

Earnings Per Share Comparative Analysis

Blueprint Medicines is currently under evaluation in earnings per share category among its peers. Earnings per Share (EPS) denotes the portion of a company's earnings that is allocated to each share of common stock. To calculate Earnings per Share investors will need to take a company's net income, subtract any dividends for preferred stock, and divide it by the number of average outstanding shares. EPS is usually presented in two different ways: basic and diluted. Fully diluted Earnings per Share takes into account effects of warrants, options, and convertible securities and is generally viewed by analysts as a more accurate measure.

Blueprint Medicines Corp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Blueprint Medicines stock to make a market-neutral strategy. Peer analysis of Blueprint Medicines could also be used in its relative valuation, which is a method of valuing Blueprint Medicines by comparing valuation metrics with similar companies.

Peers

Blueprint Medicines Related Equities

PTCTPTC Therapeutics   0.38   
0%
2.0%
DAWNDay One   0.87   
5.0%
0%
MREOMereo BioPharma   2.65   
17.0%
0%
MDGLMadrigal Pharmaceuticals   4.35   
28.0%
0%
INZYInozyme Pharma   6.12   
40.0%
0%
KRYSKrystal Biotech   7.34   
48.0%
0%
AMLXAmylyx Pharmaceuticals   7.94   
51.0%
0%
ABOSAcumen Pharmaceuticals   9.14   
59.0%
0%
XFORX4 Pharmaceuticals   13.36   
87.0%
0%
TERNTerns Pharmaceuticals   15.29   
100.0%
0%

Complementary Tools for Blueprint Stock analysis

When running Blueprint Medicines' price analysis, check to measure Blueprint Medicines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Blueprint Medicines is operating at the current time. Most of Blueprint Medicines' value examination focuses on studying past and present price action to predict the probability of Blueprint Medicines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Blueprint Medicines' price. Additionally, you may evaluate how the addition of Blueprint Medicines to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets